Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children

This study has been completed.
Information provided by:
Technische Universität Dresden Identifier:
First received: August 13, 2007
Last updated: February 12, 2009
Last verified: October 2008

The purpose of the study is to investigate, whether the FeNO concentration of asthmatic children is influenced differently by inhaled corticosteroid compared to inhaled corticosteroid + long acting beta agonist. The study hypothesis is that the FeNO concentration is more decreased in patients with a combination therapy compared to those with a corticosteroid mono therapy.

Allergic Asthma

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Technische Universität Dresden:

Estimated Enrollment: 27
Study Start Date: September 2005
Study Completion Date: October 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   6 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Allergic asthmatics


Inclusion Criteria:

  • allergic asthma since > 6 months equal or lower corticosteroid therapy before study entry FEV1>50%

Exclusion Criteria:

  • severe asthma respiratory infection within the last 4 weeks smoking
  Contacts and Locations
Please refer to this study by its identifier: NCT00515775

University Children´s Hospital, Technical University of Dresden
Dresden, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Principal Investigator: Christian Vogelberg, MD University Children´s Hospital, Technical University of Dresden
  More Information

No publications provided

Responsible Party: Dr. Christian Vogelberg, University Children's Hospital, Technical University Dresden Identifier: NCT00515775     History of Changes
Other Study ID Numbers: D5890L00015
Study First Received: August 13, 2007
Last Updated: February 12, 2009
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases processed this record on April 17, 2014